TLR4 and COVID-19: However, this effect is diminished once TLR4 signaling is genetically or pharmacologically depleted, suggesting the involvement of Toll-like receptor 4 signaling in COVID-19 cognitive dysfunction (Fontes-Dantas et al., 2023).